News Focus
News Focus
icon url

Gannicus

01/30/21 2:06 PM

#22187 RE: Nebuchadnezzar #22186

* DRWN - Medical blockchain DD & patent

https://nebula.wsimg.com/a59f3c5926a8324e72782b0318cf8e62?AccessKeyId=40BD460D4BEAC51546AB&disposition=0&alloworigin=1

https://www.globenewswire.com/news-release/2018/03/07/1417847/0/en/QuantH-QTH-Token-Listed-on-Etherscan-io.html

PATENT APPLICATION:
https://nebula.wsimg.com/d1bf519d9dd2ca7a4b065cee8d7cece6?AccessKeyId=40BD460D4BEAC51546AB&disposition=0&alloworigin=1

2018-07-25 SHAREHOLDER UPDATE:
https://www.otcmarkets.com/stock/DRWN/news/Quantum-Medical-Transport-Inc-Shareholders-Letter?id=198864


https://www.crunchbase.com/organization/quantum-medical-transport
Industries
Bitcoin
Blockchain
Health Care
Information Technology
Mobile Payments
Headquarters Regions Greater Houston Area, Southern US
Founders Ricky Bernard
Operating Status Active


Investor Relations:

Ricky Bernard
832-436-1831 x100
info@quantummedicaltransport.com
www.quantH.io
https://twitter.com/quantummedical1?lang=en


icon url

Gannicus

01/30/21 6:33 PM

#22188 RE: Nebuchadnezzar #22186

* DRWN - CEO Ricky Bernard currently owns 4.7 billion restricted shares

https://backend.otcmarkets.com/otcapi/company/financial-report/190083/content

3) Security Information
Trading Symbol: DRWN
Exact title and class of securities outstanding: Common Stock
CUSIP: 00089L107
Par Value: $0.000001 per share
Total shares authorized: 10,000,000,000 as of 3/31/2018
Total shares outstanding: 8,145,898,915 as of 3/31/2018

4) On March 9, 2017, the Issuer issued 4,700,000,000 shares of common stock to Ricky Bernard, the
Issuer’s CEO, President and sole director, in exchange for all of his shares in Quantum Medical
Holdings, Inc. a Texas corporation, of which he was the sole stockholder. These shares are
“restricted securities,” as that term is defined in Securities Act Rule 144 and bear a
legend(1) stating that the shares have not been registered under the Securities Act and (2) setting
forth or referring to the restrictions on transferability and sale of the shares under the Securities Act.